Who makes trivalent split influenza vaccine?

trivalent split influenza vaccine is developed by Novartis.

What development phase is trivalent split influenza vaccine in?

trivalent split influenza vaccine is FDA-approved (marketed).

Last reviewed 2026-04-20 · How we verify

trivalent split influenza vaccine

Novartis · FDA-approved active Biologic Quality 10/100

At a glance

Generic name	trivalent split influenza vaccine
Sponsor	Novartis
Modality	Biologic
Phase	FDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

trivalent split influenza vaccine CI brief — competitive landscape report
trivalent split influenza vaccine updates RSS · CI watch RSS
Novartis portfolio CI